June 23, 2010 at 12:22 PM EDT
Drug Pipeline Pulse Check: Roche’s Stumble Boosts Amylin
Roche Holding Ltd. (RO) and Amylin Pharmaceuticals Inc. (AMLN) A diabetes drug produced by Roche has experienced a setback after the firm said adverse reactions to the drug – Taspoglutide – have forced the company to make changes to ongoing clinical trials, creating concern over both the drug’s timeline to approval and its ability to compete successfully [...]
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here